CTL Medical Corporation partners with G-21: 3 takeaways

Dallas-based CTL Medical signed a partnership agreement with G-21 to market G-21’s bone cement, kyphoplasty and vertebroplasty technology.

Advertisement

Here are three takeaways:

 

1. Each of the cement kits comes in the form of a two component system composed of a liquid and powder. The kits offer providers safety assurance and control of mechanical properties during surgery.

 

2. CTL Medical President and CEO Daniel Chon said, “We intend to begin immediate distribution of the full line of acrylic-based bone cements for widespread procedures necessary for vertebrae consolidation and stabilization.”

 

3. G-21 is an Italian-based biomaterials company that develops long-term implantable medical devices using raw materials.

 

More articles on devices:
ECA Medical Instruments’ sterile-packed, disposable orthopedics kits see growing adoption: 4 key notes
Zimmer Biomet CEO David Dvorak exits after 10 years
DePuy Synthes releases single use kits for wrist fracture surgery: 5 key points

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

160 ambulatory leaders just ranked the EHR as the single system most overdue for AI reinvention

Tuesday, August 11
12:00 PM - 1:00 PM CDT

Presenter: Gautam Shah, MBA, FACHDM, NextGen Healthcare

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.